Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.
about
American Society of Biomechanics Journal of Biomechanics Award 2013: cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures.Chemotherapy- and irradiation-induced bone loss in adults with solid tumorsFuture of bisphosphonates and denosumab for men with advanced prostate cancer.Prostate cancer and bone: the elective affinities.Side effects of bone-targeted therapies in advanced breast cancer.HIF targets in bone remodeling and metastatic disease.Bone-targeted agents in the treatment of lung cancer.Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab.Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?Optimal sequence of bone target drugs in metastatic prostatic cancer.Bisphosphonates for advanced prostate cancer.Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review
P2860
Q27027254-D0269B49-A561-4EC9-8C98-E88B2E6DDD5EQ28084019-40B3DE88-6F28-4C84-8DE2-5FAA16F0D7C8Q33583525-FD942B18-4FE2-435A-A0E5-A06A92AFD68BQ33757791-9C266F9B-5FF9-48AF-A558-764A90AC92EFQ35066955-39C4D23E-493A-4983-B273-C0A18B5A05C8Q35554344-548A096C-D0A5-4268-942B-C85E0C06D1DFQ35780792-F48C757F-45D9-4950-A833-42EAEC3D8B37Q37443111-A3D4A403-0B94-4D3D-A7A0-5EF83E153DE9Q38195921-6FBE3F0F-3619-45B1-A9DD-FDE8022DE729Q38526456-3A2D6ED3-1224-4E2A-9392-4603D557FE9AQ47248454-102D8AB0-7385-4A7D-A423-8935EB1ACFDFQ48167919-D1C6A7D2-D854-47CE-913A-58503962D275Q58567262-D029E986-0EE6-4954-8945-271602A5E337
P2860
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Toxicities following treatment ...... with advanced prostate cancer.
@ast
Toxicities following treatment ...... with advanced prostate cancer.
@en
type
label
Toxicities following treatment ...... with advanced prostate cancer.
@ast
Toxicities following treatment ...... with advanced prostate cancer.
@en
prefLabel
Toxicities following treatment ...... with advanced prostate cancer.
@ast
Toxicities following treatment ...... with advanced prostate cancer.
@en
P2093
P2860
P1433
P1476
Toxicities following treatment ...... with advanced prostate cancer.
@en
P2093
Benjamin A Gartrell
Cora N Sternberg
Kurt Miller
Matthew D Galsky
Robert E Coleman
P2860
P304
P356
10.1016/J.EURURO.2013.05.015
P407
P50
P577
2013-05-13T00:00:00Z